Bli medlem
Bli medlem

Du är här


Camurus AB: Camurus to present at the Cowen and Company Annual Healthcare Conference 2017

Lund - 2 February 2017 - Camurus (CAMX) today announces that Fredrik
Tiberg, President and CEO, will provide an overview and update on the
company's business at the Cowen and Company 37th Annual Healthcare
Conference in Boston, Massachusetts. The presentation and the
following Q&A session will take place on Tuesday 9 March 2017 at 8:00
am Eastern Standard Time and can be accessed via a live webcast at
Camurus website An archived version of the webcast
will be available for 90 days after the event.

About Camurus
Camurus is a Swedish research-based pharmaceutical company committed
to developing and commercialising innovative and differentiated
medicines for the treatment of severe and chronic conditions. New
drug products with best-in-class potential are conceived based on the
proprietary FluidCrystal® drug delivery technologies and an extensive
R&D expertise. Camurus' clinical pipeline includes products for
treatment of cancer, endocrine diseases, pain and addiction,
developed in-house and in collaboration with international
pharmaceutical companies. The company's shares are listed on Nasdaq
Stockholm under the ticker "CAMX". For more information, visit

For more information
Fredrik Tiberg, President & CEO
Tel. +46 (0)46 286 46 92

Rein Piir, VP Investor Relations
Tel. +46 (0)70 853 72 92

The information was submitted for publication at 13.00 a.m. on 2
February 2017.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.